Skip to main content

Animations

MJFF Publications

5561 - 5570 of 6310 Results
Title
Year
  • Year
  • 2024
  • 2021
  • 2023
  • 2018
  • 2020
  • 2021
  • 2015
  • 2025
  • 2025
  • 2024
  • Summary Details
    OPEN
    Title: Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein Fibrils
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acschemneuro.4c00185
    Citation Count: 1
  • Summary Details
    OPEN
    Title: GDNF signaling in subjects with minimal motor deficits and Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105298
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Genetic Testing in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29500
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Tau immunoreactivity in peripheral tissues of human aging and select tauopathies
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2018.12.031
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2020/1694547
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson’s disease cohort
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddab058
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.07.025
    Citation Count: 47
  • Summary Details
    OPEN
    Title: A prospective controlled study of a wearable rhythmic vibrotactile device for tremor in Parkinson’s disease
    Journal Name: Clinical Neurophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.clinph.2025.02.255
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson’s Disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00907-2
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Characterizing molecular and synaptic signatures in mouse models of late‐onset Alzheimer's disease independent of amyloid and tau pathology
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13828
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.